AstraZeneca is a holding company. Through its subsidiaries, Co. is engaged in biopharmaceutical business. Co. focuses on three main therapy areas: oncology - aims to change the practice of medicine and transform the lives of patients living with cancer; cardiovascular, renal & metabolism includes treatment of four interrelated conditions - cardiovascular disease, heart failure, metabolic and renal diseases; and respiratory and immunology - aims to transform the treatment of asthma and COPD by eliminating preventable asthma attacks across disease severities and removing COPD as a cause of death through earlier, biology-led treatment. The AZN stock yearly return is shown above.
The yearly return on the AZN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the AZN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|